Raymond James Trust’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,372
Closed -$244K 691
2016
Q2
$244K Sell
3,372
-507
-13% -$34.9K 0.02% 526
2016
Q1
$250K Sell
3,879
-128
-3% -$8.49K 0.02% 511
2015
Q4
$287K Buy
4,007
+353
+10% +$26.1K 0.03% 471
2015
Q3
$280K Sell
3,654
-265
-7% -$21.4K 0.03% 438
2015
Q2
$290K Sell
3,919
-198
-5% -$14.3K 0.03% 459
2015
Q1
$299K Buy
4,117
+84
+2% +$5.84K 0.03% 444
2014
Q4
$267K Buy
4,033
+48
+1% +$2.93K 0.03% 478
2014
Q3
$219K Buy
3,985
+196
+5% +$11.1K 0.03% 526
2014
Q2
$220K Buy
3,789
+68
+2% +$4K 0.03% 526
2014
Q1
$231K Sell
3,721
-1,411
-27% -$82.1K 0.03% 480
2013
Q4
$274K Buy
5,132
+32
+0.6% +$1.72K 0.04% 422
2013
Q3
$256K Sell
5,100
-100
-2% -$4.88K 0.04% 411
2013
Q2
$238K Buy
+5,200
New +$233K 0.04% 397

Other funds holding MD

Raymond James Trust's MD Position: Q3 2016 in Review

Raymond James Trust sold out of Pediatrix Medical (MD) in Q3 2016, closing a stake of 3,372 shares — an estimated $244K sold.

Raymond James Trust first reported a position in MD in Q2 2013 and held it in 13 quarters. The position peaked at $299K in Q1 2015. 381 funds tracked by Wall St. Rank hold MD as of Q3 2016.

  • Raymond James Trust reported no remaining Pediatrix Medical position as of Q3 2016 after selling out during the quarter.
  • Raymond James Trust sold 3,372 Pediatrix Medical shares in Q3 2016, an estimated $244K.
  • Raymond James Trust first reported a position in Pediatrix Medical in Q2 2013 and held it in 13 quarters.
  • Raymond James Trust's Pediatrix Medical position peaked at $299K in Q1 2015.
  • 381 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2016.

Based on Raymond James Trust's 13F filing for Q3 2016, filed 11 Oct 2016.